Edition:
United States

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

5.80USD
4:00pm EDT
Change (% chg)

$-0.08 (-1.36%)
Prev Close
$5.88
Open
$5.90
Day's High
$5.95
Day's Low
$5.80
Volume
157,656
Avg. Vol
252,768
52-wk High
$7.39
52-wk Low
$3.95

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.21 December 21 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 4 4 4
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.43 2.38 2.38 2.38

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6 3.43 6.16 0.00 0.00
Quarter Ending Sep-18 6 4.50 7.43 0.00 0.00
Year Ending Dec-18 6 16.97 24.70 0.10 21.38
Year Ending Dec-19 6 19.56 37.08 0.10 24.03
Earnings (per share)
Quarter Ending Jun-18 5 -0.21 -0.18 -0.23 -0.21
Quarter Ending Sep-18 4 -0.21 -0.19 -0.23 -0.21
Year Ending Dec-18 5 -0.83 -0.76 -0.89 -0.72
Year Ending Dec-19 6 -0.90 -0.77 -1.00 -0.81

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 6.04 3.98 2.06 34.16
Quarter Ending Dec-17 4.93 3.89 1.04 21.03
Quarter Ending Sep-17 4.62 8.76 4.14 89.47
Quarter Ending Jun-17 5.79 3.10 2.69 46.47
Quarter Ending Mar-17 5.26 9.44 4.18 79.41

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 3.43 2.90 3.06 3.06 0.00
Quarter Ending Sep-18 4.50 3.97 3.97 3.97 0.00
Year Ending Dec-18 16.97 16.97 17.77 17.77 21.38
Year Ending Dec-19 19.56 19.56 18.33 18.33 24.03

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 1 0 1 1
Quarter Ending Sep-18 1 0 1 2
Year Ending Dec-18 0 0 0 3
Year Ending Dec-19 0 0 1 2
Earnings